Wells Fargo’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13
| Closed | -$114 | – | 7120 |
|
|
2024
Q1 | $114 | Hold |
13
| – | – | ﹤0.01% | 6228 |
|
|
2023
Q4 | $97 | Buy |
13
+1
| +8% | +$7 | ﹤0.01% | 6339 |
|
|
2023
Q3 | $69 | Hold |
12
| – | – | ﹤0.01% | 6473 |
|
|
2023
Q2 | $84 | Buy |
12
+1
| +9% | +$7 | ﹤0.01% | 6606 |
|
|
2023
Q1 | $82 | Hold |
11
| – | – | ﹤0.01% | 6659 |
|
|
2022
Q4 | $73 | Hold |
11
| – | – | ﹤0.01% | 6557 |
|
|
2022
Q3 | $0 | Buy |
11
+4
| +57% | – | ﹤0.01% | 7246 |
|
|
2022
Q2 | $0 | Sell |
7
-198
| -97% | – | ﹤0.01% | 7341 |
|
|
2022
Q1 | $4K | Sell |
205
-330
| -62% | -$6.44K | ﹤0.01% | 6191 |
|
|
2021
Q4 | $32K | Buy |
+535
| New | +$32K | ﹤0.01% | 5684 |
|
|
2021
Q3 | – | Sell |
-1,304
| Closed | -$216K | – | 7285 |
|
|
2021
Q2 | $216K | Buy |
1,304
+1,028
| +372% | +$170K | ﹤0.01% | 4700 |
|
|
2021
Q1 | $53K | Buy |
+276
| New | +$53K | ﹤0.01% | 5445 |
|